Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Change in Cash (2016 - 2025)

Historic Change in Cash for Traws Pharma (TRAW) over the last 14 years, with Q3 2025 value amounting to -$6.7 million.

  • Traws Pharma's Change in Cash rose 4195.71% to -$6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 10509.23%. This contributed to the annual value of $517000.0 for FY2024, which is 10288.25% up from last year.
  • Traws Pharma's Change in Cash amounted to -$6.7 million in Q3 2025, which was up 4195.71% from -$2.9 million recorded in Q2 2025.
  • Traws Pharma's Change in Cash's 5-year high stood at $29.0 million during Q1 2021, with a 5-year trough of -$11.5 million in Q3 2024.
  • For the 5-year period, Traws Pharma's Change in Cash averaged around -$663421.1, with its median value being -$4.3 million (2022).
  • Its Change in Cash has fluctuated over the past 5 years, first surged by 61712.87% in 2021, then tumbled by 67580.65% in 2025.
  • Over the past 5 years, Traws Pharma's Change in Cash (Quarter) stood at -$4.3 million in 2021, then rose by 10.49% to -$3.9 million in 2022, then fell by 14.7% to -$4.4 million in 2023, then soared by 460.12% to $15.9 million in 2024, then tumbled by 141.82% to -$6.7 million in 2025.
  • Its last three reported values are -$6.7 million in Q3 2025, -$2.9 million for Q2 2025, and -$5.4 million during Q1 2025.